Cystic fibrosis transmembrane conductance regulator mutations and polymorphisms associated with congenital bilateral absence of vas deferens in a restricted group of patients from North Africa.
Abstract
BACKGROUND
Congenital bilateral absence of vas deferens (CBAVD) is responsible for 2-6% of male infertility. It occurs in 95% of men
with cystic fibrosis. This malformation is present in patients with a sterile obstructive azoospermia but without clinical
evidence of cystic fibrosis. Molecular study of the cystic fibrosis transmembrane conductance regulator (CFTR) gene responsible
for cystic fibrosis could show the relationship between this disease and bilateral absence of vas deferens.
PATIENTS AND METHODS
The study involved 20 male patients aged between 28-40 years, referred with suspected cystic fibrosis and in whom bilateral
absence of vas deferens was confirmed by cyto-biochemical analyses and urogenital ultrasound. Molecular study of the CFTR
gene was based on several techniques: DHPLC, DGGE and direct sequencing.
RESULTS
Thirteen patients had CFTR mutations: F508del, G542X, W1282X, E1104X, 711+1G → T, V201M (TG) m and IVS8-5T. These mutations
were associated with polymorphisms: M470V and D1270N. Seven cases presented only polymorphisms.
CONCLUSION
The different mutations found in this study were associated with polymorphisms which decrease the severity of the disease
and delay its onset. Thus, bilateral agenesis of the vas deferens is classed as a form of cystic fibrosis with only genital
expression.
Links
Authors
Boudaya M, Fredj SH, Haj RB, Khrouf M, Bouker A, Halouani L, Messaoud T
Institution
Laboratoire de Biochimie et de Biologie Moléculaire-Hôpital d'enfants de Tunis, Tunis, Tunisia.
Source
Annals of human biology 39:1 2012 Jan pg 76-9MeSH
AdultAfrica, Northern
Cystic Fibrosis Transmembrane Conductance Regulator
Humans
Male
Male Urogenital Diseases
Mutation
Phenotype
Polymorphism, Genetic
Vas Deferens
Pub Type(s)
Journal ArticleLanguage
eng
PubMed ID
22148899
Log In

